SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue stands at Rs. 4774.14 millions for the March 2025 quarter. The mentioned figure indicates an increase of about 552.71% as against Rs. 731.43 millions during  the year-ago period.The Total Profit for the quarter ended March 2025 of Rs. 1748.77 millions grew from Rs.-400.12 millions Operating profit Margin for the quarter ended March 2025 improved to 2408.65% as compared to -0.33% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4774.14 731.43 552.71 12995.89 1719.19 655.93 12995.89 1719.19 655.93
Other Income 39.09 26.34 48.41 176.82 42.25 318.51 176.82 42.25 318.51
PBIDT 2408.65 -0.33 -729993.94 3869.57 -832.91 -564.58 3869.57 -832.91 -564.58
Interest 323.94 204.29 58.57 1616.50 894.16 80.78 1616.50 894.16 80.78
PBDT 2084.71 -204.83 -1117.78 1130.57 -2886.41 -139.17 1130.57 -2886.41 -139.17
Depreciation 335.94 195.29 72.02 1345.12 762.93 76.31 1345.12 762.93 76.31
PBT 1748.77 -400.12 -537.06 -214.55 -3649.34 -94.12 -214.55 -3649.34 -94.12
TAX 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00 0.00
Deferred Tax 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00 0.00
PAT 1748.77 -400.12 -537.06 200.00 -3649.34 -105.48 200.00 -3649.34 -105.48
Equity 114.43 40.10 185.36 114.43 40.10 185.36 114.43 40.10 185.36
PBIDTM(%) 50.45 -0.05 -111966.96 29.78 -48.45 -161.46 29.78 -48.45 -161.46

Onesource Specialty Share Price

1540.35 34.40 (2.28%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×